Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.
|Number of pages
|Giornale Italiano di Dermatologia e Venereologia
|Published - Jun 2011
All Science Journal Classification (ASJC) codes